Pfizer and BioNTech vs Omicron

By: Miguel A. Rodriguez

11:31, 13 December 2021

Preliminary effects from Pfizer and BioNTech show optimistic results against Omicron variant

Although yesterday can be considered a day of pause with little volatility in the market in general, the underlying sentiment of investors in the stock market remains somewhat more optimistic, encouraged by more positive news that highlight the effectiveness of the vaccines to protect against the Omicron virus.

Pfizer and BioNTech said Wednesday that preliminary results showed that their Covid-19 vaccine neutralized the Omicron variant of the virus after three doses. The Pfizer chief executive also said he would present the full results of his Covid-19 symptom drug Paxlovid to the US Food and Drug Administration within the first few days of next week.

The market is more inclined towards this positive news and seems to ignore the mobility restriction measures that, despite the reasonable expectations from pharmaceutical companies, are being upheld in much of Europe.

Due to the increase in cases in China, production centers and ports could reignite the supply problems and the inflationary spikes with it. The CPI data in the United States this Friday will be relevant in this regard.

Adding to that, the escalation of geopolitical tension in Russia and China could affect the supply levels. In this sense, a Pentagon official has stated that it will be necessary to urgently reinforce the self-defense groups in Taiwan as a deterrence strategy. He says that China's coercive air and sea campaigns around Taiwan increase the probability of miscalculations.

Tensions in Taiwan continue, and although they remain in the background for the moment, we must pay attention to the repercussions they may have on the markets.

Meanwhile, the North American indices closed without changes or slight gains, decoupling from the European indices, which seem to be more sensitive to the potential pandemic risks and the negative growth forecasts derived from the restrictive measures.

The German DAX index lost 0.75% after two days of upward correction. Technically it has managed to overcome the 100 and 200-day moving averages and close a previous bearish gap in a movement that can be considered simply as a corrective to the bearish momentum that started in mid-November.


Oil continues its upward correction encouraged by this better sentiment and by the talks between Iran and the United States. Their potential resolution could change the trend of this raw material drastically. 

The uncertainty about the evolution of global oil demand for next year is another factor to take into account given the forecasts of an economic slowdown and the possible negative effects of the restrictive circulation measures that are already being implemented in much of the world.

Technically it has surpassed the 200-day moving average and is approaching the 100-day moving average, but it is still in a downtrend with this latest movement of a purely corrective nature.


Sources: Bloomberg, Reuters

Share this article

The information presented herein is prepared by and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.                                                                                                                            Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience, or current financial situation.Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance and forecasts are not reliable indicators of future results.